Cardiorespiratory Requirements of the 6-Min Walk Test in Older Patients with Left Ventricular Systolic Dysfunction and No Major Structural Heart Disease

Abstract

The six-minute walk test (6-MWT) is widely used to assess functional status in patients with chronic heart failure (CHF). The aims of the present study were: (1) to compare metabolic gas exchange during the 6-MWT in older patients with left ventricular systolic dysfunction (LVSD) and in breathless patients with no major structural heart disease (MSHD); (2) to determine the exercise intensity of the 6-MWT relative to peak oxygen uptake; (3) to establish the accuracy and reproducibility of the Metamax 3B ergospirometer during an incremental workload. Twenty four older patients with LVSD (19 male; age 76 ± 5 years; BMI 27 ± 4), and 18 patients with no MSHD (12 male; age 75 ± 8 years; BMI 27 ± 4) attended on consecutive days at the same time. Patients completed a 6-MWT with metabolic gas exchange measurements using the Metamax 3B portable ergospirometer, and an incremental cycle ergometry test using both the Metamax 3B and Oxycon Pro metabolic cart. Patients returned and performed a second 6-MWT and an incremental treadmill test, metabolic gas exchange was measured with the Metamax 3B. In patients with LVSD, the 6-MWT was performed at a higher fraction of maximal exercise capacity (p = 0.02). The 6-MWT was performed below the anaerobic threshold in patients with LVSD (83 %) and in patients with no MSHD (61 %). The Metamax 3B showed satisfactory to high accuracy at 10 W and 20 W in patients with LVSD (r = 0.77 - 0.97, p < 0.05), and no MSHD (r = 0.76 - 0.94, p < 0.05). Metabolic gas exchange variables measured during the 6-MWT showed satisfactory to high day-to-day reproducibility in patients with LVSD (ICC = 0.75 - 0.98), but a higher variability was evident in participants with no MSHD (ICC = 0.62 - 0.97). The Metamax 3B portable ergospirometer is an accurate and reproducible device during submaximal, fixed rate exercise in older patients with LVSD and no MSHD. In elderly patients with LVSD and no MSHD, the 6-MWT should not be considered a maximal test of exercise capacity but rather a test of submaximal exercise performance. Our study demonstrates that the 6-MWT takes place at a higher proportion of peak oxygen uptake in patients with LVSD compared to those with no MSHD, and may be one reason why fatigue is a more prominent symptom in these patients.

Key words

anaerobic threshold - heart failure - accuracy - reproducibility

References

• 1 ATS Statement: Guidelines for the six-minute walk test.  Am J Respir Crit Care Med. 2002;  166 1111-1117
• 2 Beaver W L, Wasserman K, Whipp B J. A new method for detecting anaerobic threshold by gas exchange.  J App Physiol. 1986;  60 2020-2027
• 3 Bittner V, Weiner D H, Yusuf S, Rogers W J, McIntyre K M, Bangdiwala S I, Kronenberg M W, Kostis J B, Kohn R M, Guillotte M. Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction.  JAMA. 1993;  270 1702-1707
• 4 Cahalin L P, Mathier M A, Semigran M J, Dec G W, DiSalvo T G. The six-minute walk test predicts peak oxygen uptake and survival in patients with advanced heart failure.  Chest. 1996;  110 325-332
• 5 Carter J, Jeukendrup A E. Validity and reliability of three commercially available breath-by-breath respiratory systems.  Eur J Appl Physiol. 2002;  86 435-441
• 6 Cleland J GF, Torabi A, Khan N K. Epidemiology and management of heart failure and left ventricular systolic dysfunction in the aftermath of a myocardial infarction.  Heart. 2005;  91 (Suppl II) ii7-ii13
• 7 Faggiano P, D'Aloia A, Gualeni A, Lavatelli A, Giordano A. Assessment of oxygen uptake during the 6 minute walking test in patients with heart failure: preliminary experience with a portable device.  Am Heart J. 1997;  134 203-206
• 8 Foray A, Williams D, Reemtsma K, Oz M, Mancini D. Assessment of submaximal exercise capacity in patients with left ventricular devices.  Circulation. 1996;  94 II222-II2226
• 9 Foss O, Hallen J. Validity and stability of a computerized metabolic system with mixing chamber.  Int J Sports Med. 2005;  26 569-575
• 10 Gayda M, Temfemo A, Choquet D, Ahmaidi S. Cardiorespiratory requirements and reproducibility of the six-minute walk test in elderly patients with coronary artery disease.  Arch Phys Med Rehabil. 2004;  85 1538-1543
• 11 Guyatt G H, Sullivan M J, Thompson P J, Fallen E L, Pugsley S O, Taylor D W, Berman L B. The six minute walk: a new measure of exercise capacity in patients with chronic heart failure.  Can Med Assoc J. 1985;  132 919-923
• 12 Hodges L D, Brodie D A, Bromley P D. Validity and reliability of selected commercially available metabolic analyzer systems.  Scand J Med Sci Sports. 2005;  15 271-285
• 13 Ingle L, Shelton R J, Rigby A S, Nabb S, Clark A L, Cleland J G. The reproducibility and sensitivity of the six-minute walk test in patients with chronic heart failure.  Eur Heart J. 2005;  26 1742-1751
• 14 Ingle L, Shelton R J, Cleland J G, Clark A L. Poor relationship between exercise capacity and spirometric measurements in patients with more symptomatic heart failure.  J Card Fail. 2005;  11 619-623
• 15 Ingle L, Rigby A S, Nabb S, Jones P K, Clark A L, Cleland J G. Clinical determinants of poor six-minute walk test performance in patients with left ventricular systolic dysfunction and no major structural heart disease.  Eur J Heart Fail. 2006;  8 321-325
• 16 Ingle L, Goode K, Rigby A S, Cleland J G, Clark A L. Predicting peak oxygen uptake from 6-min walk test performance in male patients with left ventricular systolic dysfunction.  Eur J Heart Fail. 2006;  8 198-202
• 17 Kervio G, Ville N S, Leclercq C, Daubert J C, Carre F. Intensity and reliability of the six-minute walk test in moderate chronic heart failure patients.  Arch Phys Med Rehabil. 2004;  85 1513-1518
• 18 Kober L, Torp-Pedersen C, Jorgensen S, Eliasen P, Camm A J. Changes in absolute and relative importance in the prognostic value of the left ventricular systolic function and congestive heart failure after acute myocardial infarction.  Am J Cardiol. 1998;  81 1292-1297
• 19 Larsson P U, Wadell K M, Jakobsson E J, Burlin L U, Henriksson-Larsson K B. Validation of the MetaMax II portable metabolic measurement system.  Int J Sports Med. 2004;  25 115-123
• 20 Lipkin D P, Scriven A J, Crake T, Poole-Wilson P A. Six-minute walking test for assessing exercise capacity in chronic heart failure.  Br Med J. 1986;  292 653-655
• 21 Macfarlane D J. Automated metabolic gas analysis systems: a review.  Sports Med. 2001;  31 841-861
• 22 Medbø J I, Mamen A, Welde B, von Heimburg E, Stokke R. Examination of the Metamax I and II oxygen analysers during exercise studies in the laboratory.  Scand J Clin Lab Invest. 2002;  62 585-598
• 23 Meyer T, Georg T, Becker C, Kindermann W. Reliability of gas exchange measurements from two different spiroergometry systems.  Int J Sports Med. 2001;  22 593-597
• 24 Meyer T, Davison R C, Kindermann W. Ambulatory gas exchange measurements - current status and future options.  Int J Sports Med. 2005;  26 (Suppl 1) S19-S27
• 25 National Institute for Clinical Excellence (NICE) .Chronic heart failure. Management of chronic heart failure in adults in primary and secondary care. London; NICE, Clinical Guidelines 2003: 5
• 26 Olsson L G, Swedberg K, Clark A L, Witte K K, Cleland J G. Six minute corridor walk test as an outcome measure for the assessment and treatment in randomised, blinded intervention trials of chronic heart failure: a systematic review.  Eur Heart J. 2005;  26 778-793
• 27 Remme W J, Swedberg K. Comprehensive guidelines for the diagnosis and treatment of chronic heart failure. Task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology.  Eur J Heart Fail. 2002;  4 11-22
• 28 Rietgens G JWM, Kuipers H, Kester A DM. Validation of a computerized metabolic measurement system (Oxycon Pro) during low and high intensity exercise.  Int J Sports Med. 2001;  22 291-294
• 29 Riley M, McParland J, Stanford C F, Nicholls D P. Oxygen consumption during corridor walk testing in chronic cardiac failure.  Eur Heart J. 1992;  13 789-793
• 30 Schiller N B, Shah P M, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I. Recommendations for quantification of the left ventricle by two-dimensional echocardiography.  J Am Soc Echocardiogr. 1989;  2 358-367